Meguro City, Japan | 26th February 2026 - 27th February 2026
Targeted Therapies Licensing & Partnering Asia
Accelerate licensing and co-development of ADCs, TPD, and RLT in Asia. Connect global pharma with innovative biotech at this premier Tokyo partnering summit.
The site is part of theHanson Wadedivision atHanson Wade Group.About Us|Products|Contact Us
Hanson Wade Limited is registered in England & Wales, number 06752216. Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.
February 26-27, 2026 | Tokyo, Japan
February 26-27, 2026 | Tokyo, Japan
With fast, cost-effective clinical infrastructure, generous government incentives, and simplified regulatory pathways, Asia’s biotech ecosystem has emerged as a global launchpad for innovation. Western pharma and biotech companies are increasingly turning to de-risked assets from Asia to supercharge their clinical pipelines and gain a competitive edge.